Why?Will heme-onc go down in competitiveness because of COVID ?
Wouldn't chemotherapy be delayed until COVID cools down ?Why?
As I've pointed out elsewhere, the only non-COVID stuff going on in the hospitals and clinics where I work is cancer, STEMI, transplant and trauma.
My 6 floor hospital-based office building has only 3 clinics open regular hours right now...Hem/Onc, Gyn Onc and Surg Onc. Everyone else (GI, OB/gyn, primary care, peds, nephrology, neurology, gen surg) are skeleton crews right now.
In a few cases. But not when you're dealing in curative intent treatment, or giving patients with significant symptoms from metastatic disease, palliative therapy.Wouldn't chemotherapy be delayed until COVID cools down ?
Did you have a lot of research/projects etc.?Doable. Its unmatch rate has climbed but a usmd from an academic program still has good odds. About on par with heme/onc as firstcontact said.
I got in a decent university fellowship in Chicago as a USMD from a community program and lower steps than yours, though full disclosure I got in on my 2nd try.